Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$1.2 - $2.17 $21,121 - $38,194
-17,601 Reduced 47.87%
19,165 $32,000
Q2 2024

Jul 29, 2024

SELL
$1.36 - $3.65 $32,112 - $86,183
-23,612 Reduced 39.11%
36,766 $50,000
Q1 2024

Apr 29, 2024

SELL
$3.52 - $9.59 $3,854 - $10,501
-1,095 Reduced 1.78%
60,378 $226,000
Q4 2023

Feb 07, 2024

SELL
$5.97 - $10.36 $16,423 - $28,500
-2,751 Reduced 4.28%
61,473 $603,000
Q3 2023

Nov 02, 2023

BUY
$8.23 - $13.93 $36,936 - $62,517
4,488 Added 7.51%
64,224 $536,000
Q2 2023

Aug 07, 2023

SELL
$9.97 - $14.05 $9,521 - $13,417
-955 Reduced 1.57%
59,736 $794,000
Q1 2023

May 09, 2023

BUY
$7.94 - $12.02 $95,335 - $144,324
12,007 Added 24.66%
60,691 $702,000
Q4 2022

Feb 09, 2023

SELL
$5.67 - $11.2 $1,383 - $2,732
-244 Reduced 0.5%
48,684 $398,000
Q3 2022

Nov 09, 2022

BUY
$3.93 - $8.57 $48,311 - $105,351
12,293 Added 33.56%
48,928 $284,000
Q2 2022

Aug 10, 2022

SELL
$4.02 - $10.43 $43,190 - $112,059
-10,744 Reduced 22.68%
36,635 $162,000
Q1 2022

May 09, 2022

SELL
$8.43 - $20.9 $7,224 - $17,911
-857 Reduced 1.78%
47,379 $431,000
Q4 2021

Feb 09, 2022

SELL
$19.26 - $30.08 $353,517 - $552,118
-18,355 Reduced 27.56%
48,236 $986,000
Q3 2021

Nov 09, 2021

SELL
$24.86 - $35.02 $125,741 - $177,131
-5,058 Reduced 7.06%
66,591 $1.7 Million
Q2 2021

Aug 10, 2021

SELL
$22.3 - $36.02 $101,844 - $164,503
-4,567 Reduced 5.99%
71,649 $2.51 Million
Q1 2021

May 10, 2021

SELL
$26.38 - $51.15 $23,662 - $45,881
-897 Reduced 1.16%
76,216 $2.54 Million
Q4 2020

Feb 08, 2021

BUY
$10.5 - $28.5 $222,316 - $603,430
21,173 Added 37.85%
77,113 $2 Million
Q3 2020

Nov 06, 2020

BUY
$3.61 - $9.87 $548 - $1,500
152 Added 0.27%
55,940 $552,000
Q2 2020

Aug 05, 2020

BUY
$2.65 - $4.03 $94,832 - $144,217
35,786 Added 178.91%
55,788 $193,000
Q1 2020

May 12, 2020

BUY
$2.36 - $5.26 $2,119 - $4,723
898 Added 4.7%
20,002 $61,000
Q4 2019

Feb 05, 2020

SELL
$4.6 - $5.57 $14,931 - $18,080
-3,246 Reduced 14.52%
19,104 $98,000
Q3 2019

Nov 13, 2019

BUY
$4.99 - $6.16 $21,152 - $26,112
4,239 Added 23.41%
22,350 $115,000
Q2 2019

Aug 12, 2019

SELL
$5.92 - $7.41 $6,204 - $7,765
-1,048 Reduced 5.47%
18,111 $110,000
Q1 2019

May 10, 2019

SELL
$6.8 - $7.4 $113,784 - $123,824
-16,733 Reduced 46.62%
19,159 $139,000
Q4 2018

Feb 14, 2019

SELL
$3.99 - $7.82 $34,198 - $67,025
-8,571 Reduced 19.28%
35,892 $265,000
Q3 2018

Nov 14, 2018

BUY
$3.52 - $5.55 $19,824 - $31,257
5,632 Added 14.5%
44,463 $240,000
Q2 2018

Aug 13, 2018

BUY
$2.11 - $3.92 $7,074 - $13,143
3,353 Added 9.45%
38,831 $0
Q1 2018

May 14, 2018

SELL
$2.05 - $3.23 $1,320 - $2,080
-644 Reduced 1.78%
35,478 $72,000
Q4 2017

Feb 13, 2018

BUY
$2.59 - $5.44 $57,744 - $121,284
22,295 Added 161.24%
36,122 $95,000
Q3 2017

Nov 02, 2017

BUY
$3.2 - $5.57 $44,246 - $77,016
13,827
13,827 $73,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $434M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.